Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-09-25
1998-01-06
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514495, 514557, A61K 3155, C07D47114
Patent
active
057054991
ABSTRACT:
Disclosed are novel are useful in the treatment of HIV-1 infection.
REFERENCES:
patent: 5366972 (1994-11-01), Hargrave
Hargrave, K. et al; "Novel Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. 1. Tricyclic Pyridobenzo-Dipyridodiazepinones" Journal of Medicinal Chemistry vol. 34 No. 7, 1991 pp. 2231-2241 XP002020340.
Cywin Charles L.
Hoermann MaryAnn
Klunder Janice M.
Boehringer Ingelheim Pharmaceuticals Inc.
Bond Robert T.
Raymond Robert P.
Rieder Wendy E.
Stempel Alan R.
LandOfFree
8-arylalkyl- and and their use in the treatment of HIV-1 infecti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-arylalkyl- and and their use in the treatment of HIV-1 infecti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-arylalkyl- and and their use in the treatment of HIV-1 infecti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329321